Description
GLISOT-1 Tablet contains Glimepiride 1 mg, an oral antidiabetic medicine belonging to the sulfonylurea class. It is used alongside diet and exercise to help improve blood glucose control in adults with type 2 diabetes mellitus when prescribed by a qualified healthcare professional. Glimepiride stimulates insulin release from pancreatic beta cells, helping lower elevated blood glucose levels.
Glimepiride 1 mg may be prescribed as part of an individualized diabetes treatment plan, either alone or alongside other glucose-lowering medicines when clinically appropriate. Regular blood glucose monitoring, consistent meals, physical activity and medical follow-up remain important elements of diabetes management. The medicine is not intended to treat type 1 diabetes or diabetic ketoacidosis.
CardianCare focuses on cardiac and diabetic healthcare products for healthcare professionals and pharmaceutical business partners. Businesses researching a Glimepiride 1 mg Tablets manufacturer India can enquire about product availability, approved specifications and applicable quality documentation.
For pharmaceutical procurement teams evaluating a Glimepiride 1 mg Tablets manufacturer and supplier India, important considerations include composition accuracy, product authorization, manufacturing source, batch traceability, packaging, shelf life and commercial supply terms.
2. Key Ingredient
Composition:
Glimepiride 1 mg
Glimepiride is an oral antidiabetic agent classified as a sulfonylurea. It works by stimulating insulin secretion from pancreatic beta cells, helping the body reduce elevated blood glucose levels in people with type 2 diabetes.
Unlike medicines that act primarily by reducing glucose production in the liver or increasing glucose excretion through urine, Glimepiride promotes insulin release. Because this action can continue even when glucose levels are low, hypoglycaemia is an important safety consideration.
For businesses researching a Glimepiride 1 mg pharmaceutical company India, procurement assessments should include product composition, approved labelling, manufacturing authorization, quality systems and applicable regulatory documentation.
Companies seeking a Glimepiride 1 mg medicine manufacturer India should verify the product’s regulatory status, manufacturing source, batch documentation and relevant quality requirements before establishing a supply arrangement.
3. Key Benefits
Blood glucose management: Helps improve glycaemic control in adults with type 2 diabetes when prescribed appropriately.
Insulin secretion support: Stimulates insulin release from pancreatic beta cells.
established medicine class: Belongs to the sulfonylurea class of oral antidiabetic medicines.
Low-strength treatment option: The 1 mg strength allows a prescriber to consider a lower starting dose when appropriate.
Combination therapy option: May be used with selected other antidiabetic medicines under medical supervision.
Comprehensive diabetes care: Can form part of a broader management plan involving nutrition, exercise and regular glucose monitoring.
The clinical response varies according to individual health status, meal patterns, other medicines and treatment adherence. Glimepiride is not suitable for every patient, and the risk of low blood glucose must be assessed.
Pharmaceutical buyers searching for a Glimepiride 1 mg supplier India should verify product authenticity, availability, batch details, shelf life and relevant documentation before procurement.
An enquiry for a Glimepiride 1 mg Tablet wholesaler and distributor India may involve product availability, distribution eligibility, order requirements, delivery arrangements and applicable commercial terms.
Businesses looking for a Glimepiride 1 mg bulk supplier India should request relevant product documentation and confirm packaging specifications, expiry information, storage requirements and supply conditions.
A Glimepiride 1 mg pharmaceutical distributor India should verify product authorization, maintain appropriate storage and distribution practices, and use approved product information when communicating with healthcare professionals.
4. How Does It Work?
Glimepiride stimulates insulin release from pancreatic beta cells. It binds to sulfonylurea receptors associated with ATP-sensitive potassium channels, leading to channel closure and changes in the cell membrane potential. This triggers calcium entry into the cells and promotes insulin secretion.
The released insulin helps body tissues take up glucose from the bloodstream, contributing to improved blood glucose control in people with type 2 diabetes.
Because Glimepiride stimulates insulin secretion, it can cause hypoglycaemia, particularly when meals are missed, calorie intake is reduced, alcohol is consumed or other glucose-lowering medicines are used. Treatment should therefore be individualized and monitored by a healthcare professional.
5. Directions for Use
Dosage: Take Glimepiride 1 mg only as prescribed by a doctor. The appropriate dose depends on blood glucose levels, meal patterns, other medicines and individual clinical factors.
Administration: Follow the approved product label and the prescriber’s instructions. Glimepiride is commonly taken with breakfast or the first main meal of the day.
Regular timing: Follow a consistent daily schedule and avoid changing the dose without medical advice.
Meals: Do not skip meals after taking the medicine, as this can increase the risk of hypoglycaemia.
Blood glucose monitoring: Monitor blood glucose as recommended by the treating clinician.
Missed dose: Follow the patient information leaflet or ask a doctor or pharmacist for advice. Do not take a double dose to compensate for a missed dose.
Lifestyle management: Continue recommended dietary measures, physical activity and follow-up appointments.
Dose adjustment: Any adjustment should be made by the prescriber based on clinical response and the risk of low blood glucose.
The 1 mg strength is not necessarily the correct dose for every patient. Follow the approved product information and individualized medical advice.
6. Possible Side Effects
Possible side effects associated with Glimepiride include:
Hypoglycaemia or low blood glucose.
Sweating, shakiness, dizziness or sudden hunger.
Headache or weakness.
Nausea or other gastrointestinal discomfort.
Temporary visual disturbances, particularly when blood glucose levels change.
Weight gain in some patients.
Allergic skin reactions in some individuals.
Seek urgent medical attention for severe hypoglycaemia, confusion, seizures, loss of consciousness or symptoms of a serious allergic reaction, such as facial swelling or difficulty breathing.
Severe or persistent symptoms should be assessed by a healthcare professional. This list is not exhaustive, and individual reactions may vary.
7. Safety Information
Medical supervision: Use only under the guidance of a qualified healthcare professional.
Type 1 diabetes: Glimepiride is not appropriate for treating type 1 diabetes or diabetic ketoacidosis.
Hypoglycaemia: Risk increases with skipped meals, fasting, reduced calorie intake, strenuous exercise, alcohol and certain drug interactions.
Kidney function: Patients with impaired kidney function may be more vulnerable to hypoglycaemia and require careful medical assessment and dose selection.
Liver health: Inform the doctor about liver disease, as it may affect treatment suitability and the risk of adverse effects.
Pregnancy: Consult a doctor before use during pregnancy or when planning pregnancy. The clinician should determine the most appropriate diabetes treatment.
Breastfeeding: Seek medical advice before use while breastfeeding because treatment suitability and potential infant risks must be assessed.
Drug interactions: Inform the prescriber about all prescription medicines, over-the-counter products and supplements. Some medicines may increase or reduce Glimepiride’s glucose-lowering effect.
Alcohol: Alcohol may affect blood glucose control and increase the risk of adverse reactions. Discuss alcohol use with the treating clinician.
Driving and machinery: Low blood glucose can impair concentration and reaction time. Patients should understand their individual risk before driving or operating machinery.
Storage: Store in the original packaging according to the approved product label, protected from excessive heat and moisture and out of children’s reach.
This information is educational and does not replace approved prescribing information or individualized medical advice.
8. B2B Pharmaceutical Business Enquiries
CardianCare focuses on cardiac and diabetic healthcare products for healthcare professionals and pharmaceutical business partners. Distributors, wholesalers, pharmacists and procurement teams can enquire about current product availability and applicable commercial arrangements directly with the company.
Businesses searching for a Glimepiride 1 mg PCD pharma franchise India opportunity should confirm whether the product is available through a current programme. Territory availability, partner eligibility, product range and commercial terms require direct verification.
For a Glimepiride 1 mg Tablets PCD pharma franchise enquiry, prospective partners may request information about eligible products, applicable order requirements, distribution conditions and approved promotional materials.
Companies exploring a Glimepiride 1 mg Tablet PCD franchise should verify the availability of the relevant product and programme before making investment or promotional commitments.
Businesses researching Glimepiride 1 mg third party manufacturing India should confirm whether the proposed company offers such services. If applicable, due diligence should include manufacturing permissions, product approvals, applicable GMP compliance, quality agreements and batch-release procedures.
A Glimepiride 1 mg Tablet third party manufacturer India enquiry should cover the manufacturing facility’s authorization, formulation specifications, quality control, packaging requirements, batch documentation and contractual responsibilities.
Companies investigating Glimepiride 1 mg contract manufacturing India should verify service availability and assess regulatory responsibilities, quality agreements, manufacturing authorization, technical documentation, minimum batch quantities and commercial feasibility.
Visit https://CardianCare.com/ to contact CardianCare regarding current product availability, pharmaceutical business enquiries and applicable arrangements. Franchise, distribution and manufacturing services must be confirmed directly with the company before being represented as available.
For more information about GLISOT-1 Tablet (Glimepiride 1 mg), click here












Reviews
There are no reviews yet.